{"data":{"ticker":"VKTX","name":"Viking Therapeutics, Inc.","cik":"0001607678","quarterly":[{"frame":"CY2023Q3","end":"2023-09-30","revenue":0,"netIncome":-22534000,"epsDiluted":-0.23,"fiscalPeriod":"Q3 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2023Q4","end":"2023-12-31","revenue":0,"netIncome":-24605000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2024Q1","end":"2024-03-31","revenue":0,"netIncome":-27356000,"epsDiluted":-0.26,"fiscalPeriod":"Q1 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q2","end":"2024-06-30","revenue":0,"netIncome":-22250000,"epsDiluted":-0.2,"fiscalPeriod":"Q2 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q3","end":"2024-09-30","revenue":0,"netIncome":-24940000,"epsDiluted":-0.22,"fiscalPeriod":"Q3 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q4","end":"2024-12-31","revenue":0,"netIncome":-35417000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2025Q1","end":"2025-03-31","revenue":0,"netIncome":-45629000,"epsDiluted":-0.41,"fiscalPeriod":"Q1 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q2","end":"2025-06-30","revenue":0,"netIncome":-65561000,"epsDiluted":-0.58,"fiscalPeriod":"Q2 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q3","end":"2025-09-30","revenue":0,"netIncome":-90787000,"epsDiluted":-0.81,"fiscalPeriod":"Q3 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q4","end":"2025-12-31","revenue":0,"netIncome":-157662000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2026Q1","end":"2026-03-31","revenue":0,"netIncome":-158325000,"epsDiluted":-1.37,"fiscalPeriod":"Q1 FY 2026","fiscalYear":"FY 2026"},{"frame":"CY2026Q2","end":"2026-06-30","revenue":0,"netIncome":-128022000,"epsDiluted":-1.1,"fiscalPeriod":"Q2 FY 2026","fiscalYear":"FY 2026"}],"annual":[{"frame":"CY2020","end":"2020-12-31","fiscalYear":"FY 2020","revenue":0,"netIncome":-39495000,"operatingCashFlow":-21777000,"capex":null,"buybacks":null,"dividends":null},{"frame":"CY2021","end":"2021-12-31","fiscalYear":"FY 2021","revenue":0,"netIncome":-54990000,"operatingCashFlow":-47586000,"capex":null,"buybacks":null,"dividends":null},{"frame":"CY2022","end":"2022-12-31","fiscalYear":"FY 2022","revenue":0,"netIncome":-68867000,"operatingCashFlow":-48397000,"capex":null,"buybacks":6795000,"dividends":null},{"frame":"CY2023","end":"2023-12-31","fiscalYear":"FY 2023","revenue":0,"netIncome":-85895000,"operatingCashFlow":-73376000,"capex":null,"buybacks":null,"dividends":null},{"frame":"CY2024","end":"2024-12-31","fiscalYear":"FY 2024","revenue":0,"netIncome":-109963000,"operatingCashFlow":-87790000,"capex":null,"buybacks":null,"dividends":null},{"frame":"CY2025","end":"2025-12-31","fiscalYear":"FY 2025","revenue":0,"netIncome":-359639000,"operatingCashFlow":-278685000,"capex":null,"buybacks":null,"dividends":null}],"latest":{"end":"2026-06-30","cash":125750000,"debt":null,"equity":408317000,"assets":521898000,"sharesOutstanding":116652937,"sharesDate":"2026-07-15","form":"10-Q"},"source":"SEC XBRL companyfacts, values as filed in USD"},"updatedAt":"2026-10-14T05:10:19.304Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Financial statement data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}